| Business: |
(Incorporated in Delaware)
We manufacture citrus drinks – both branded and private label beverages.
We are a pioneer in the “UltraFresh” juice category through our end-to-end cold chain platform. Our factory is in Dallas. But we intend to open a plant in South Carolina in 2026 and in the Arizona- Nevada corridor in 2027.
Our product portfolio consists of fresh citrus juice, a fresh citrus-based line of lemonades and wellness shot offerings across multiple brand lines and retail customers, all produced using our cold chain process: Buda Juice (Organic) – Wellness shots in 2-ounce format and also available in 2-pack and 6-pack glass bottle configurations; Buda Fresh – Value-Forward Offering (Non-Organic) – 12-ounce Lime Juice, 16-ounce and 128-ounce Lemon Juice; Fresh Orange and Grapefruit juice (16-ounce and 52-ounce), and Fresh citrus-based Lemonades and Limeades (16-ounce and 52-ounce) and Private Label Products (Non-organic and Organic): Fresh Citrus Line of products (52 ounce) and Fresh citrus-based Lemonades and Limeades (52 ounce) rsification and private label manufacturing capabilities, allowing us to serve multiple market segments while leveraging our core cold chain production platform. The organic wellness shots represent our premium positioning, and our conventional fresh citrus juices, fresh citrus-based line of lemonades and private label offerings provide broader market access and volume scale in the UltraFreshTM category.
The strategic focus on citrus as our foundational ingredient provides exceptional product development flexibility and speed-to-market advantages. Since citrus serves as the natural base for our entire portfolio—from fresh orange juice to tasty lemonades—we can rapidly innovate by pairing this stable, high-quality foundation with seasonal fruits, and fun creative ingredients.
Note: Net income and revenue are for the 12 months that ended Dec. 31, 2024.
(Note: Buda Juice filed its S-1/A for its IPO on Oct. 20, 2025, and disclosed the terms: 2.7 million shares at a price range of $7.50 to $9.00 to raise $22.0 million, if priced at the $8.25 mid-point of its range. Of the 2.7 million shares in the IPO, the company is offering 2.0 million shares and the selling shareholder is offering 666,667 shares, according to the prospectus. Background: Buda Juice filed its S-1 on Aug. 27, 2025.)
|
